Vascular Biogenics Ltd (NASDAQ: VBLT) stock closed at $3.78 on 11/21/23 after a major increase of 11.2%. The stock has risen 24.7% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, VBLT is expected to continue to be a modest Value Eraser.
Vascular Biogenics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Vascular Biogenics has a neutral Appreciation Score of 51 but a poor Power Rating of 30, triggering the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment